Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults

ClinicalTrials.gov ID: NCT05014568

Public ClinicalTrials.gov record NCT05014568. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 16, 2026, 9:34 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Efficacy and Safety Study of Tapinarof for the Treatment of Moderate to Severe Atopic Dermatitis in Children and Adults

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a double-blind, randomized, vehicle controlled Phase 3 study to evaluate the efficacy and safety of topical tapinarof cream, 1% compared to vehicle control cream in pediatric and adult subjects with atopic dermatitis.

Study identification

NCT ID
NCT05014568
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Organon and Co
Industry
Enrollment
407 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
2 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 1, 2021 (Actual)
Primary completion
Mar 30, 2023 (Actual)
Completion
Apr 7, 2023 (Actual)
Last update posted
Sep 4, 2025

2021 – 2023

United States locations

U.S. sites
60
U.S. states
24
U.S. cities
56
Facility City State ZIP Site status
Dermavant Investigative Site Birmingham Alabama 35244 —
Dermavant Investigative Site Phoenix Arizona 85032 —
Dermavant Investigative Site Bryant Arkansas 72022 —
Dermavant Investigative Site Beverly Hills California 90212 —
Dermavant Investigative Site Fountain Valley California 92708 —
Dermavant Investigative Site Fremont California 94538 —
Dermavant Investigative Site Inglewood California 90301 —
Dermavant Investigative Site Los Angeles California 90017 —
Dermavant Investigative Site Los Angeles California 90033 —
Dermavant Investigative Site Mission Viejo California 92691 —
Dermavant Investigative Site Sacramento California 95815 —
Dermavant Investigative Site Washington D.C. District of Columbia 20037 —
Dermavant Investigative Site Boca Raton Florida 33431 —
Dermavant Investigative Site Boca Raton Florida 33486 —
Dermavant Investigative Site Brandon Florida 33511 —
Dermavant Investigative Site Coral Gables Florida 33146 —
Dermavant Investigative Site Jacksonville Florida 32256 —
Dermavant Investigative Site Margate Florida 33063 —
Dermavant Investigative Site Miami Florida 33126 —
Dermavant Investigative Site Miami Lakes Florida 33014 —
Dermavant Investigative Site Orlando Florida 32801 —
Dermavant Investigative Site Pinellas Park Florida 33781 —
Dermavant Investigative Site Sweetwater Florida 33172 —
Dermavant Investigative Site Tampa Florida 33615 —
Dermavant Investigative Site Marietta Georgia 30060 —
Dermavant Investigative Site Sandy Springs Georgia 30328 —
Dermavant Investigative Site Savannah Georgia 31406 —
Dermavant Investigative Site Plainfield Indiana 46168 —
Dermavant Investigative Site Louisville Kentucky 40217 —
Dermavant Investigative Site Owensboro Kentucky 42301 —
Dermavant Investigative Site Covington Louisiana 70433 —
Dermavant Investigative Site Monroe Louisiana 71201 —
Dermavant Investigative Site Largo Maryland 20774 —
Dermavant Investigative Site Bay City Michigan 48706 —
Dermavant Investigative Site Clarkston Michigan 48346 —
Dermavant Investigative Site Warren Michigan 48088 —
Dermavant Investigative Site Ypsilanti Michigan 48197 —
Dermavant Investigative Site New Brighton Minnesota 55112 —
Dermavant Investigative Site Missoula Montana 59808 —
Dermavant Investigative Site Omaha Nebraska 68144 —
Dermavant Investigative Site Garden City New York 11530 —
Dermavant Investigative Site New York New York 10075 —
Dermavant Investigative Site Bexley Ohio 43209 —
Dermavant Investigative Site Cleveland Ohio 44106 —
Dermavant Investigative Site Oklahoma City Oklahoma 73071 —
Dermavant Investigative Site Oklahoma City Oklahoma 73120 —
Dermavant Investigative Site Gresham Oregon 97030 —
Dermavant Investigative Site Portland Oregon 97223 —
Dermavant Investigative Site Hershey Pennsylvania 17033 —
Dermavant Investigative Site Greenville South Carolina 29615 —
Dermavant Investigative Site Knoxville Tennessee 37909 —
Dermavant Investigative Site Austin Texas 78745 —
Dermavant Investigative Site Bellaire Texas 77401 —
Dermavant Investigative Site Cypress Texas 77433 —
Dermavant Investigative Site Dallas Texas 75230 —
Dermavant Investigative Site Houston Texas 77098 —
Dermavant Investigative Site San Antonio Texas 78218 —
Dermavant Investigative Site San Antonio Texas 78229 —
Dermavant Investigative Site Sugar Land Texas 77479 —
Dermavant Investigative Site Richmond Virginia 23226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05014568, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 4, 2025 · Synced Oct 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05014568 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →